NCT06433635 Sequential Multiple Assignment Randomized Trial for Bipolar Depression Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06328140 Sleep Quality, Cognitive Performance, and Computerized Cognitive Training Status WITHDRAWN Phase N/A
NCT05351736 Impact of Structural and Myelin Abnormalities on Cognitive Impairments in Recent-onset Schizophrenia - Before and After Lurasidone Treatment (MARYLU) Status UNKNOWN Phase PHASE4
NCT05213143 The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine Status TERMINATED Phase PHASE4
NCT05011669 The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT04312503 Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia" Status COMPLETED Phase N/A
NCT03902613 18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder Status COMPLETED Phase PHASE4
NCT03557931 A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication Status COMPLETED Phase PHASE2
NCT03304457 Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia Status COMPLETED Phase PHASE4
NCT02893371 Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies Status TERMINATED Phase N/A
NCT02731612 Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients Status COMPLETED Phase PHASE3